Tiziana Life Sciences (TLSA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
TLSA ends flat (+0.0%) to $1.05, 5 down days in a row. Closed at $1.05, +0.00% vs the prior close of $1.05. Day range $1.03–$1.10, opened at $1.08.
TLSA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — TLSA ends flat (+0.0%) to $1.05, 5 down days in a row
- Closed at $1.05, +0.00% vs the prior close of $1.05. Day range $1.03–$1.10, opened at $1.08.
- Volume was 558.77K shares, 0.7x its 50-day average of 823.70K.
- Price is +1.9% vs its 50-day average ($1.03) and -15.4% vs its 200-day average ($1.24).
- 52-week range $0.76–$2.15; today's close sits at 21% of that range, 51.2% below the 52-week high.
- That makes 5 straight losses.
Oct 15, 2026 — TLSA ends flat (+0.0%) to $1.05, 4 down days in a row
- Closed at $1.05, +0.00% vs the prior close of $1.05. Day range $1.02–$1.07, opened at $1.05.
- Volume was 264.40K shares, 0.3x its 50-day average of 838.12K — lighter than usual.
- Price is +2.1% vs its 50-day average ($1.03) and -15.5% vs its 200-day average ($1.24).
- 52-week range $0.76–$2.20; today's close sits at 20% of that range, 52.3% below the 52-week high.
- That makes 4 straight losses.
Oct 14, 2026 — TLSA slides 3.7% to $1.05, 3 down days in a row
- Closed at $1.05, -3.67% vs the prior close of $1.09. Day range $1.03–$1.08, opened at $1.06.
- Volume was 581.40K shares, 0.7x its 50-day average of 838.04K.
- Price is +2.2% vs its 50-day average ($1.03) and -15.7% vs its 200-day average ($1.25).
- 52-week range $0.76–$2.20; today's close sits at 20% of that range, 52.3% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — TLSA ends flat (+0.0%) to $1.09
- Closed at $1.09, +0.00% vs the prior close of $1.09. Day range $1.05–$1.12, opened at $1.09.
- Volume was 492.60K shares, 0.6x its 50-day average of 888.44K — lighter than usual.
- Price is +6.3% vs its 50-day average ($1.03) and -12.6% vs its 200-day average ($1.25).
- 52-week range $0.76–$2.20; today's close sits at 23% of that range, 50.5% below the 52-week high.
Oct 12, 2026 — TLSA slides 8.4% to $1.09
- Closed at $1.09, -8.40% vs the prior close of $1.19. Day range $1.07–$1.20, opened at $1.20.
- Volume was 567.60K shares, 0.6x its 50-day average of 884.86K.
- Price is +6.5% vs its 50-day average ($1.02) and -12.8% vs its 200-day average ($1.25).
- 52-week range $0.76–$2.25; today's close sits at 22% of that range, 51.6% below the 52-week high.
Oct 9, 2026 — TLSA jumps 5.3% to $1.19, a 1-month high on 2.9x normal volume
- Closed at $1.19, +5.31% vs the prior close of $1.13. Day range $1.13–$1.25, opened at $1.14.
- Volume was 2.42M shares, 2.9x its 50-day average of 836.70K — unusually heavy trading.
- Price is +16.4% vs its 50-day average ($1.02) and -4.9% vs its 200-day average ($1.25).
- 52-week range $0.76–$2.30; today's close sits at 28% of that range, 48.3% below the 52-week high.
Oct 8, 2026 — TLSA rises 2.7% to $1.13
- Closed at $1.13, +2.73% vs the prior close of $1.10. Day range $1.11–$1.15, opened at $1.11.
- Volume was 449.90K shares, 0.5x its 50-day average of 828.82K — lighter than usual.
- Price is +11.0% vs its 50-day average ($1.02) and -9.8% vs its 200-day average ($1.25).
- 52-week range $0.76–$2.33; today's close sits at 24% of that range, 51.5% below the 52-week high.
Oct 7, 2026 — TLSA dips 0.9% to $1.10
- Closed at $1.10, -0.90% vs the prior close of $1.11. Day range $1.07–$1.14, opened at $1.11.
- Volume was 384.60K shares, 0.5x its 50-day average of 826.45K — lighter than usual.
- Price is +8.5% vs its 50-day average ($1.01) and -12.4% vs its 200-day average ($1.26).
- 52-week range $0.76–$2.33; today's close sits at 22% of that range, 52.8% below the 52-week high.
Oct 6, 2026 — TLSA jumps 3.7% to $1.11
- Closed at $1.11, +3.74% vs the prior close of $1.07. Day range $1.05–$1.14, opened at $1.08.
- Volume was 628.20K shares, 0.8x its 50-day average of 816.18K.
- Price is +9.7% vs its 50-day average ($1.01) and -11.7% vs its 200-day average ($1.26).
- 52-week range $0.76–$2.33; today's close sits at 22% of that range, 52.4% below the 52-week high.
Oct 5, 2026 — TLSA slides 4.5% to $1.07
- Closed at $1.07, -4.46% vs the prior close of $1.12. Day range $1.07–$1.14, opened at $1.12.
- Volume was 274.40K shares, 0.3x its 50-day average of 817.27K — lighter than usual.
- Price is +6.2% vs its 50-day average ($1.01) and -15.0% vs its 200-day average ($1.26).
- 52-week range $0.76–$2.33; today's close sits at 20% of that range, 54.1% below the 52-week high.
Oct 2, 2026 — TLSA dips 1.8% to $1.12
- Closed at $1.12, -1.75% vs the prior close of $1.14. Day range $1.10–$1.20, opened at $1.16.
- Volume was 436.80K shares, 0.5x its 50-day average of 818.34K — lighter than usual.
- Price is +11.6% vs its 50-day average ($1.00) and -11.2% vs its 200-day average ($1.26).
- 52-week range $0.76–$2.33; today's close sits at 23% of that range, 51.9% below the 52-week high.
TLSA latest news & SEC filings
Every SEC filing by or about TLSA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Oct 16, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 30, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Elrifi Ivor converted options/RSUs into 1,050,000 shares on Aug 15, 2026; now holds 5,843,684
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 21, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Sep 17, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 24, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 7, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Cerrone Gabriele M bought 42,357 shares at $0.99 (≈$41.93K) on Jul 21, 2026
- Cerrone Gabriele M bought 42,357 shares at $0.99 (≈$41.93K) on Jul 21, 2026
- Cerrone Gabriele M bought 42,357 shares at $0.99 (≈$41.93K) on Jul 21, 2026
- Cerrone Gabriele M bought 42,357 shares at $0.99 (≈$41.93K) on Jul 21, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 7, 2026 · Form 4/A — Insider trade (amended)
Amended insider trade report (Form 4/A)
- Cerrone Gabriele M bought 15,000 shares at $1.11 (≈$16.65K) on Jun 12, 2026
- Cerrone Gabriele M bought 15,000 shares at $1.11 (≈$16.65K) on Jun 12, 2026
- Cerrone Gabriele M bought 15,000 shares at $1.11 (≈$16.65K) on Jun 12, 2026
- Cerrone Gabriele M bought 15,000 shares at $1.11 (≈$16.65K) on Jun 12, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 6, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Elrifi Ivor bought 237,616 shares at $1.00 (≈$237.62K) on Aug 5, 2026
- Elrifi Ivor bought 237,616 shares at $1.00 (≈$237.62K) on Aug 5, 2026
- Elrifi Ivor bought 237,616 shares at $1.00 (≈$237.62K) on Aug 5, 2026
- Elrifi Ivor bought 237,616 shares at $1.00 (≈$237.62K) on Aug 5, 2026
- Elrifi Ivor bought 83,807 shares at $0.97 (≈$81.29K) on Aug 4, 2026
- Elrifi Ivor bought 83,807 shares at $0.97 (≈$81.29K) on Aug 4, 2026
- …plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 6, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Aug 5, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Elrifi Ivor bought 667,000 shares at $1.00 (≈$667.00K) on Aug 3, 2026
- Elrifi Ivor bought 667,000 shares at $1.00 (≈$667.00K) on Aug 3, 2026
- Elrifi Ivor bought 667,000 shares at $1.00 (≈$667.00K) on Aug 3, 2026
- Elrifi Ivor bought 667,000 shares at $1.00 (≈$667.00K) on Aug 3, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 4, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Jul 31, 2026 · Form 6-K — Report from a foreign company (6-K)
Report from a foreign company (6-K) — news it published at home
Things to know before you trade TLSA
- How much it moves: over the last 20 sessions the average daily move was 4.03% (largest 18.0%). That is a volatile stock.
- Liquidity: about 700.00K shares (≈$735.00K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.05 vs a range of $0.76–$2.15 (21% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 0 sales; latest: Ivor Elrifi bought 237,616 shares on Aug 5, 2026.
- Latest filings: 6-K Oct 16, 2026; 6-K Oct 16, 2026; 6-K Sep 30, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
TLSA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.08 | 1.10 | 1.03 | 1.05 | 558.77K |
| Oct 15, 2026 | 1.05 | 1.07 | 1.02 | 1.05 | 264.40K |
| Oct 14, 2026 | 1.06 | 1.08 | 1.03 | 1.05 | 581.40K |
| Oct 13, 2026 | 1.09 | 1.12 | 1.05 | 1.09 | 492.60K |
| Oct 12, 2026 | 1.20 | 1.20 | 1.07 | 1.09 | 567.60K |
| Oct 9, 2026 | 1.14 | 1.25 | 1.13 | 1.19 | 2.42M |
| Oct 8, 2026 | 1.11 | 1.15 | 1.11 | 1.13 | 449.90K |
| Oct 7, 2026 | 1.11 | 1.14 | 1.07 | 1.10 | 384.60K |
| Oct 6, 2026 | 1.08 | 1.14 | 1.05 | 1.11 | 628.20K |
| Oct 5, 2026 | 1.12 | 1.14 | 1.07 | 1.07 | 274.40K |
| Oct 2, 2026 | 1.16 | 1.20 | 1.10 | 1.12 | 436.80K |
| Oct 1, 2026 | 1.11 | 1.19 | 1.09 | 1.14 | 697.70K |
| Sep 30, 2026 | 1.00 | 1.14 | 0.97 | 1.11 | 1.52M |
| Sep 29, 2026 | 0.98 | 1.03 | 0.94 | 0.95 | 511.30K |
| Sep 28, 2026 | 1.01 | 1.05 | 0.96 | 0.98 | 389.00K |
| Sep 25, 2026 | 1.03 | 1.08 | 1.00 | 1.01 | 382.70K |
| Sep 24, 2026 | 1.10 | 1.11 | 1.00 | 1.04 | 706.60K |
| Sep 23, 2026 | 0.89 | 1.06 | 0.89 | 1.05 | 1.57M |
| Sep 22, 2026 | 0.89 | 0.89 | 0.87 | 0.89 | 623.90K |
| Sep 21, 2026 | 0.94 | 0.95 | 0.90 | 0.90 | 534.30K |
About Tiziana Life Sciences
Tiziana Life Sciences (TLSA) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in LONDON, ENGLAND, United Kingdom. State of incorporation: Bermuda. Fiscal year ends December 31. SEC CIK 1723069.
TLSA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Gabriele M Cerrone | Director | Aug 7, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Ivor Elrifi | Chief Executive Officer | Sep 29, 2026 |
| Keeren Rameshchandra Shah | CHIEF OPERATING & FIN. OFFICER | May 22, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 5, 2026 | Ivor Elrifi | Buy | 237,616 | $1.00 |
| Aug 5, 2026 | Ivor Elrifi | Buy | 237,616 | $1.00 |
| Aug 5, 2026 | Ivor Elrifi | Buy | 237,616 | $1.00 |
| Aug 5, 2026 | Ivor Elrifi | Buy | 237,616 | $1.00 |
| Aug 4, 2026 | Ivor Elrifi | Buy | 83,807 | $0.97 |
| Aug 4, 2026 | Ivor Elrifi | Buy | 83,807 | $0.97 |
| Aug 4, 2026 | Ivor Elrifi | Buy | 83,807 | $0.97 |
| Aug 4, 2026 | Ivor Elrifi | Buy | 83,807 | $0.97 |
| Aug 3, 2026 | Ivor Elrifi | Buy | 667,000 | $1.00 |
| Aug 3, 2026 | Ivor Elrifi | Buy | 667,000 | $1.00 |
| Aug 3, 2026 | Ivor Elrifi | Buy | 667,000 | $1.00 |
| Aug 3, 2026 | Ivor Elrifi | Buy | 667,000 | $1.00 |
| Jul 21, 2026 | Gabriele M Cerrone | Buy | 42,357 | $0.99 |
| Jul 21, 2026 | Gabriele M Cerrone | Buy | 42,357 | $0.99 |
| Jul 21, 2026 | Gabriele M Cerrone | Buy | 42,357 | $0.99 |
TLSA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $—, total liabilities $—, cash $—.
TLSA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on TLSA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.